I'm out. Took my measly profits and looking elsewhere. A partner may or may not come, but the iHub thing has to much hype. There are lot of great biotech's that don't get any attention on iHub. That was my signal to get out. Merck just formed collaboration with a little biotech Advaxis. It may just be too late for Peregrine. The risk is not worth it. Had a hard time selling at 18600 shares on top of it. If they really wanted it they would have grabbed it at the bid. But they did'nt. Best of luck PPHM longs. Moving on to newer pastures. Thanks for the pocket change.
Your words "I think the 129 sites where an omen and it really is part of numerology. Once $1.46 breaks we will see that $1.29 level. I'm looking to buy some right around the next break after $1.29 near $1.19. iHubers are happy because to them its just another opportunity to buy at low rates after losing half their current investment"
Why would you even consider buying any at all, if this company is such a loser ? How do you know what iHubers are doing ?
What happened to your concern about constitutional rights and the rights of free speech in America.
I have gotten many leads from IHub on this subject. It's more than a color change anyway. Partnership cannot be accessed. That means they updating the site. That's it. I think.
It is presently not accessible. Are they preparing to updated with new information ?
Quoted By Dr. Yopp at the Annual Society of Surgical Oncology Meeting on Mar 14, 2014 about Peregrine's Combination of Bavituximab with Sorafenib for Liver Cancer.
"The Phase II portion of this trial is ongoing with 34 of the 38 intended patients currently enrolled, 10 of which are currently on treatment with the longest one on treatment for 18 months," said Dr. Yopp. "This open-labeled trial is almost complete and while the results are preliminary, they are promising. I am excited about this potential combination given the new understandings about bavituximab's mechanism and I look forward to sharing the full set of data from this Phase II trial later this year."
Dr. Yopp will be speaking about and presenting poster presentations about Hepatocellular Carcinoma.
Authors Index page 93 015, O-017, P-096, P-191, P-192, P-193, P-194
From abstracts list at the ILCA’s 8th Annual Conference
If this is all true then why are you and your boys harping up a storm of criticism now ? If you are so sure of a dilution or reverse split, why not just wait and catch longs off guard. Why not go ahead and short more by encouraging people to buy more share like shorts usually do before some negative event.
It is nice to see that one of the Sunrise Phase III clinical trial sites is being conducted at the Moffitt Cancer Center in Florida . From post 187372 on IHub semper
We are not talking about a merger, acquisition or partnership here. You are talking about a hostile take over where another company would come in and take over Peregrine against our will. Kind of like an invading Ebola virus. Is that what you want or Peregrine ? Do you really think that would be in the best interest of shareholders at this point ? I don't see it, but maybe you could explain.
You are a bit confused. They already sold their shares and now they can not buy them back because no one will sell them to them. That is why they created a negative spike today to drive through some stops. I knew it was coming. It was grabby time. Did you short get your fill ? Lets try again boys and girls. Adam is hungry.
I'ts just a matter of time. hang in there reed. Don't let these chumps get to you. They are here for a reason.
TO STEAL SHARES !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
United States Lung Cancers.
165,402 Deaths per year. 7.95 % rate of all deaths. Worlds rank #9
Age adjusted death rate of 35.38 per 1000
The only ones sleepy around here are learningcurveball and antwan_rockamoron
Greece has many if not most of the Sunrise trial sites. Greece also is ranked 16th in the world for lung cancer with 6497 deaths a year. 9.34% of total deaths. 31.16 per 100,000 of population.
If you really think these sites will go sleepy then you have no Idea what you are talking about.
Go to" World Life Expectancy " and you can see why these countries have asked Peregrine to to be part of their Sunrise trial.
I really hope you are all short. And hold them tight to your chests. So when things happen, you'll be gone.
Protection of Human Subjects; Informed Consent (January 27, 1981)
Protection of Human Research Subjects; Standards for Institutional Review Boards for Clinical Investigations (January 27, 1981)
Protection of Human Research Subjects; Clinical Investigations Which May Be Reviewed Through Expedited Review Procedure Set Forth in FDA Regulations (January 27, 1981)
Protection of Human Subjects; Informed Consent; Standards for Institutional Review Boards for Clinical Investigations (November 1988)
Federal Policy for the Protection of Human Subjects (June 18, 1991)
FDA Policy for the Protection of Human Subjects (June 18, 1991)
Protection of Human Subjects; Informed Consent; Proposed Rule (September 21, 1995)
Protection of Human Subjects; Informed Consent, Part II (October 2, 1996) [html]
Protection of Human Subjects; Informed Consent and Waiver of Informed Consent Requirements in Certain Emergency Research; Final Rules (October 2, 1996) [text]
Protection of Human Subjects; Informed Consent (December 22, 1995)
Protection of Human Subjects; Informed Consent Verification; Final Rule (November 5, 1996)
Categories of Research That May Be Reviewed by the Institutional Review Board (IRB) Through an Expedited Review Procedure (November 9, 1998)
Protection of Human Subjects; Informed Consent, Exception from general requirements (October 5, 1999)
Additional protections for children (66 FR 20589-600, April 24, 2001)
Exception from General Requirements for Informed Consent (71 FR 32827, June 7, 2006)